Literature DB >> 17011078

Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin.

Stéphane Boghossian1, Naohiko Ueno, Michael G Dube, Pushpa Kalra, Satya Kalra.   

Abstract

Leptin, a product of the ob gene, is a pleiotropic signal implicated in regulation of multiple physiological functions in the periphery and centrally, including hypothalamic integration of energy homeostasis. Recessive mutations of ob gene result in early onset of hyperphagia, morbid obesity, metabolic disorders, early mortality and shortened life-span. Intracerebroventricular injection of recombinant adeno-associated virus vector (rAAV) encoding the leptin gene in adult obese ob/ob mice enhanced leptin transgene expression only in the hypothalamus, normalized food intake, body weight and more than doubled the life-span as compared to control cohorts and extended it to near that of normal wild type mice. These life-extending benefits were associated with drastic reductions in visceral fat, and blood glucose and insulin levels, but elevated ghrelin levels, the anti-aging biomarkers. Thus, bioavailability of leptin transduced by ectopic gene in the hypothalamus alone is both necessary and sufficient to normalize life-span. Evidently, site-specific ectopic gene expression with rAAV is durable and safe for alleviating neural disorders that stem from missing or functional disruption of a single gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17011078     DOI: 10.1016/j.neurobiolaging.2006.08.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  21 in total

Review 1.  To subjugate NPY is to improve the quality of life and live longer.

Authors:  Satya P Kalra; Pushpa S Kalra
Journal:  Peptides       Date:  2007-01-09       Impact factor: 3.750

Review 2.  Nucleic acid therapy for lifespan prolongation: present and future.

Authors:  Wing-Fu Lai
Journal:  J Biosci       Date:  2011-09       Impact factor: 1.826

3.  Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss.

Authors:  Russell T Turner; Michael Dube; Adam J Branscum; Carmen P Wong; Dawn A Olson; Xiaoying Zhong; Mercedes F Kweh; Iske V Larkin; Thomas J Wronski; Clifford J Rosen; Satya P Kalra; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2015-10-20       Impact factor: 4.286

4.  Leptin stimulates bone formation in ob/ob mice at doses having minimal impact on energy metabolism.

Authors:  Kenneth A Philbrick; Carmen P Wong; Adam J Branscum; Russell T Turner; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2017-01-05       Impact factor: 4.286

5.  Hypothalamic leptin gene therapy prevents weight gain without long-term detrimental effects on bone in growing and skeletally mature female rats.

Authors:  Urszula T Iwaniec; Stéphane Boghossian; Cynthia H Trevisiol; Thomas J Wronski; Russell T Turner; Satya P Kalra
Journal:  J Bone Miner Res       Date:  2011-07       Impact factor: 6.741

6.  Body mass influences cortical bone mass independent of leptin signaling.

Authors:  U T Iwaniec; M G Dube; S Boghossian; H Song; W G Helferich; R T Turner; S P Kalra
Journal:  Bone       Date:  2008-11-27       Impact factor: 4.398

7.  Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay.

Authors:  Satya P Kalra; Michael G Dube; Urszula T Iwaniec
Journal:  Peptides       Date:  2009-02-07       Impact factor: 3.750

Review 8.  Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation.

Authors:  Satya P Kalra
Journal:  Peptides       Date:  2009-08-06       Impact factor: 3.750

9.  Effects of hypothalamic leptin gene therapy on osteopetrosis in leptin-deficient mice.

Authors:  Kenneth A Philbrick; Stephen A Martin; Amy R Colagiovanni; Adam J Branscum; Russell T Turner; Urszula T Iwaniec
Journal:  J Endocrinol       Date:  2017-11-30       Impact factor: 4.286

Review 10.  Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches.

Authors:  Satya P Kalra
Journal:  Nutrition       Date:  2008-09       Impact factor: 4.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.